UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033107
Receipt number R000037730
Scientific Title Prospective study regarding the improving effect of Ninjinyoeito on frailty and sarcopenia in older adults
Date of disclosure of the study information 2018/06/23
Last modified on 2019/03/14 18:59:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study regarding the improving effect of Ninjinyoeito on frailty and sarcopenia in older adults

Acronym

The effect of Ninjinyoeito on frailty and sarcopenia

Scientific Title

Prospective study regarding the improving effect of Ninjinyoeito on frailty and sarcopenia in older adults

Scientific Title:Acronym

The effect of Ninjinyoeito on frailty and sarcopenia

Region

Japan


Condition

Condition

Older adults with frailty or prefrailty

Classification by specialty

Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate whether Ninjinyoeito,a Kampo Medicine, is effective for treating older adults with frailty or prefrailty.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Changes in appetite, dietary composition, and physical activity.

Key secondary outcomes

Changes in the component of frailty, MMSE score, and body compositoin.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Treatment with Ninjinyoeito for 24 weeks

Interventions/Control_2

Observation without treatment for 24 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. 65 years old or older
2. Outpatient who can walk by himself
3. MMSE score more than 24 points
4. Patient applicable of more than one item of frailty by J-CHS
5. Patient who does not correspond to exclusion criteria

Key exclusion criteria

1. Patient who has allergic episode with Ninjinyoeito in the past
2. Patient who took Kampo medicine preparation within two weeks before examination

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ken Shinmura

Organization

Hyogo College of Medicine

Division name

Division of General Medicine, Department of Internal Medicine

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

TEL

0798-45-6865

Email

ke-shimmura@hyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ken Shinmura

Organization

Hyogo College of Medicine

Division name

Division of General Medicine, Department of Internal Medicine

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

TEL

0798-45-6865

Homepage URL


Email

ke-shimmura@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫医科大学ささやま医療センター


Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 07 Month 01 Day

Date of IRB

2017 Year 09 Month 22 Day

Anticipated trial start date

2017 Year 09 Month 23 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2019 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded



Other

Other related information

Because the necessary numerical cases did not gather, I decided to terminate this examination.


Management information

Registered date

2018 Year 06 Month 22 Day

Last modified on

2019 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037730


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name